Antares Pharma to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference
May 09 2013 - 7:00AM
Business Wire
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K.
Wotton, Ph.D., President and Chief Executive Officer, will present
at the Bank of America Merrill Lynch 2013 Healthcare Conference on
Thursday May 16, 2013 at 10:40 am PDT.
A live webcast of the presentation will be available via the
“Investor Relations” page of the Antares website,
www.antarespharma.com. A replay of the webcast will also be
archived on Antares’ website for 90 days following the
presentation.
About Antares Pharma
Antares Pharma focuses on self-administered parenteral
pharmaceutical products and topical gel-based medicines. The
Company is developing OTREXUP™, a combination product for the
delivery of methotrexate using Medi-Jet™ technology for the
treatment of rheumatoid arthritis, poly-articular-course juvenile
rheumatoid arthritis and psoriasis, as well as VIBEX™ QS T for
testosterone replacement therapy. The Company's technology
platforms include VIBEX™ disposable Medi-Jet™, disposable multi-use
pen injectors and Vision™ reusable needle-free injectors marketed
as Tjet® and Zomajet® by Teva Pharmaceutical Industries, Ltd (Teva)
and Ferring Pharmaceuticals (Ferring), respectively. Antares Pharma
has a multi-product deal with Teva that includes Tev-Tropin® human
growth hormone (hGH), VIBEX™ epinephrine and several other
products. Antares Pharma’s partnership with Ferring includes
Zomacton® hGH. In the U.S. Antares has received FDA approval for
Gelnique 3%™, a treatment for overactive bladder that is marketed
by Actavis. Elestrin® (estradiol gel) is FDA approved for the
treatment of moderate-to-severe vasomotor symptoms associated with
menopause, and is marketed in the U.S. by Meda Pharma. Antares
Pharma has two facilities in the U.S. The Parenteral Products Group
located in Minneapolis, Minnesota directs the manufacturing and
marketing of the Company’s reusable needle-free injection devices
and related disposables, and develops its disposable
pressure-assisted Medi-Jet and pen injector systems. The Company’s
corporate office and Product Development and Commercial Groups are
located in Ewing, New Jersey.
Antares Pharma (NASDAQ:ATRS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Antares Pharma (NASDAQ:ATRS)
Historical Stock Chart
From Jul 2023 to Jul 2024